Joseph Lane

Hospital for Special Surgery, New York

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

14 more share only the name and are not shown

Trial papers

170

PubMed author-name match

Trials

Studies that name Joseph Lane as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:31 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT04249232 · Abaloparatide and Pelvic Fracture Healing
Hospital for Special Surgery, New York · completed · Fracture of Pelvis (Disorder) · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 03:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 14 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

MUSCULOSKELETAL RESEARCH TRAINING
T32AR007281 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · fiscal years 1986 to 2006 · $52,189 awarded in 2006
Same name and institution; not confirmed by an ID
BIOMEDICAL RESEARCH SUPPORT
S07RR005495 · NCRR · HOSPITAL FOR SPECIAL SURGERY · fiscal years 1991 · $23,623 awarded in 1991
Same name and institution; not confirmed by an ID
MOLECULAR BIOLOGY OF FRACTURE INJURY AND REPAIR
R01AM019776 · NIADDK · HOSPITAL FOR SPECIAL SURGERY · fiscal years 1985 · $139,995 awarded in 1985
Same name and institution; not confirmed by an ID

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:31 UTC. The ranking covers the 200 most relevant of 170 PubMed records, and a shared surname and initials can bring in a namesake. All 170 on PubMed

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med · 2016
2,057 citations
RCR 82.8
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med · 2016
1,046 citations
RCR 43.4
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med · 2023
740 citations
RCR 83.6
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
JAMA · 2020
678 citations
RCR 30.5
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
JAMA · 2018
330 citations
RCR 12.2
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
J Clin Oncol · 1998
243 citations
RCR 7.0
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
BMJ · 2012
213 citations
RCR 6.9
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
Lancet Oncol · 2014
190 citations
RCR 5.9
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
Br J Nutr · 2009
185 citations
RCR 6.1
Stress management improves long-term glycemic control in type 2 diabetes.
Diabetes Care · 2002
177 citations
RCR 5.5